APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+7.92%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.7B
AUM Growth
+$3.7B
(+3.2%)
Cap. Flow
+$51.7M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
146
New
53
Increased
24
Reduced
24
Closed
34
Top Buys
| 1 |
Eli Lilly
LLY
|
$130M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$129M |
| 3 |
Hologic
HOLX
|
$80.7M |
| 4 |
Biogen
BIIB
|
$63.7M |
| 5 |
NeoGenomics
NEO
|
$61.7M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$182M |
| 2 |
Intuitive Surgical
ISRG
|
$103M |
| 3 |
AbbVie
ABBV
|
$66.8M |
| 4 |
Avantor
AVTR
|
$64.1M |
| 5 |
Medtronic
MDT
|
$60.7M |
Sector Composition
| 1 | Healthcare | 95.4% |
| 2 | Technology | 1.61% |
| 3 | Financials | 0.67% |
| 4 | Consumer Discretionary | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $53.2M | 1.44% |
568,000
-13,000
| -2% | -$1.22M |
|
|
BPMC
27
DELISTED
Blueprint Medicines
BPMC
| $49.5M | 1.34% |
563,200
+17,200
| +3% | +$1.51M |
|
28
Natera
NTRA
$23.3B
| $49.5M | 1.34% |
436,000
+40,400
| +10% | +$4.59M |
|
29
Sotera Health
SHC
$4.57B
| $46.3M | 1.25% |
1,910,000
+749,000
| +65% | +$18.1M |
|
|
XLRN
30
DELISTED
Acceleron Pharma Inc.
XLRN
| $45M | 1.22% |
358,500
+35,700
| +11% | +$4.48M |
|
31
IDEAYA Biosciences
IDYA
$2.3B
| $43.4M | 1.17% |
2,070,000
+598,000
| +41% | +$12.6M |
|
32
United Therapeutics
UTHR
$17.9B
| $42.4M | 1.15% |
+236,400
| New | +$42.4M |
|
33
BridgeBio Pharma
BBIO
$9.93B
| $41.1M | 1.11% |
673,400
-141,700
| -17% | -$8.64M |
|
34
Alphatec Holdings
ATEC
$2.33B
| $40.2M | 1.09% |
2,621,000
+287,000
| +12% | +$4.4M |
|
|
TRIL
35
DELISTED
Trillium Therapeutics Inc.
TRIL
| $39.8M | 1.08% |
4,105,000
+90,000
| +2% | +$873K |
|
|
CYT
36
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $38.7M | 1.05% |
+1,808,394
| New | +$38.7M |
|
|
CMPS
37
Compass Pathways
CMPS
$449M
| $38.2M | 1.03% |
+1,000,000
| New | +$38.2M |
|
38
Cardinal Health
CAH
$35.8B
| $37.3M | 1.01% |
654,200
-808,800
| -55% | -$46.2M |
|
|
KDMN
39
DELISTED
Kadmon Holdings, Inc.
KDMN
| $36M | 0.97% |
9,294,600
-249,600
| -3% | -$966K |
|
40
Dynavax Technologies
DVAX
$1.18B
| $33.5M | 0.91% |
3,400,000
-100,000
| -3% | -$985K |
|
41
Alnylam Pharmaceuticals
ALNY
$59.2B
| $33.1M | 0.89% |
195,000
-232,969
| -54% | -$39.5M |
|
42
Insmed
INSM
$30.6B
| $32.7M | 0.88% |
+1,150,050
| New | +$32.7M |
|
|
SPNE
43
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $31.3M | 0.85% |
+1,524,998
| New | +$31.3M |
|
44
Lifestance Health
LFST
$2.15B
| $30.6M | 0.83% |
+1,100,000
| New | +$30.6M |
|
45
Century Therapeutics
IPSC
$42.4M
| $29.4M | 0.8% |
+1,003,522
| New | +$29.4M |
|
46
Legend Biotech
LEGN
$6.65B
| $25.7M | 0.69% |
+625,000
| New | +$25.7M |
|
47
Immunocore
IMCR
$1.73B
| $23.5M | 0.63% |
601,000
+51,000
| +9% | +$1.99M |
|
48
Adicet Bio
ACET
$61.8M
| $23.2M | 0.63% |
2,250,500
+20,500
| +0.9% | +$211K |
|
49
Acadia Pharmaceuticals
ACAD
$4.31B
| $22.9M | 0.62% |
+940,000
| New | +$22.9M |
|
|
LENZ
50
LENZ Therapeutics
LENZ
$1.1B
| $22.6M | 0.61% |
+735,500
| New | +$22.6M |
|